NUVL Insider Trading Activity and SEC Form 4 Filings
NUVL insider trading summary
Over the past 12 months, insiders at Nuvalent, Inc. (NUVL) reported 143 sales worth $615.3M by 15 insiders and no open-market purchases on SEC Form 4. Net insider selling was $615.3M.
Latest NUVL insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Jul 9, 2026 | Henry E. Pelish | Chief Scientific Officer | Sell | $261K (2,111 @ $123.81) |
| Jul 6, 2026 | James Richard Porter | President and CEO | Sell | $3.7M (30,000 @ $123.72) |
| Jul 1, 2026 | Alexandra Balcom | Chief Financial Officer | Sell | $1.4M (11,430 @ $123.58) |
| Jul 1, 2026 | Darlene Noci | Chief Development Officer | Sell | $2.8M (23,000 @ $123.59) |
| Jun 29, 2026 | Darlene Noci | Chief Development Officer | Sell | $679K (5,500 @ $123.51) |
| Jun 9, 2026 | Darlene Noci | Chief Development Officer | Sell | $2.5M (20,000 @ $122.81) |
| Jun 8, 2026 | James Richard Porter | President and CEO | Sell | $1.1M (12,495 @ $87.97) |
| Jun 8, 2026 | James Richard Porter | President and CEO | Sell | $272K (3,036 @ $89.63) |
| Jun 8, 2026 | James Richard Porter | President and CEO | Sell | $1.3M (14,469 @ $88.79) |
| Jun 1, 2026 | Alexandra Balcom | Chief Financial Officer | Sell | $21K (200 @ $103.84) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.